approved

Приложение 4 на ПЛС от 02.11.2019 г.

Unique identificator:  9bc14123-eddd-4804-993b-4d554402e443

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2019-11-11 16:52:26
  • Created by: georgi_sivchev
  • Updated at: 2019-11-11 16:52:26
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Escitalopram 20090436 Elicea, Film coated tablet, 20, mg, Pack: 28 KRKA, d.d., Словения KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Словения 13.1 2.62 15.72 6% 0.79 13.89 2.78 16.67 18% 2.36 16.25 3.25 19.5 НСР-6688/09.07.2015 25.07.2015 25.07.2015 Неактивен 4032
Venlafaxine 20080092 Elify XR, prolonged‐release capsule, hard, 150, mg, Pack: 30 Medochemie Ltd., Кипър Medochemie Ltd., Cyprus 12.58 2.52 15.1 6% 0.75 13.33 2.67 16 18% 2.26 15.59 3.12 18.71 Цената се заличава с решение НСР-3149/26.03.2014 HCР-521/11.07.2013. 29.07.2013 29.07.2013 Заличен 1972
Venlafaxine II-2248/ 11.06.2008 Elify XR, prolonged‐release capsule, hard, 150, mg, Pack: 30 Medochemie Ltd., Кипър Medochemie Ltd, Cyprus 31.8 6.36 38.16 4% 1.27 33.07 6.61 39.68 16% 5.09 38.16 7.63 45.79 КЦРР-210/27.02.2012 20.03.2012 20.03.2012 Неактивен 1972
Venlafaxine II-2248/11.06.2008 Elify XR, prolonged‐release capsule, hard, 150, mg, Pack: 30 Medochemie Ltd., Кипър Medochemie Ltd, Cyprus 42.25 8.45 50.7 6% 2.54 44.79 8.96 53.75 18% 7.61 52.4 10.48 62.88 КЦ-494/04.02.2009 24.02.2009 24.02.2009 Неактивен 1972
Venlafaxine 20080091 ELIFY XR, Prolonged release capsule, hard, 75, mg, Pack: 30 Medochemie Ltd., Кипър Medochemie Ltd., Cyprus 5.32 1.06 6.38 7% 0.37 5.69 1.14 6.83 20% 1.06 6.75 1.35 8.1 Корекционно решение НСР-18621/25.04.2019 HCР-7710/17.12.2015; НСР-18287/28.03.2019 12.04.2019 02.06.2019 Активен 1971
Venlafaxine 20080091 ELIFY XR, Prolonged release capsule, hard, 75, mg, Pack: 30 Medochemie Ltd., Кипър Medochemie Ltd., Cyprus 5.32 1.06 6.38 7% 0.37 5.69 1.14 6.83 20% 1.06 6.75 1.35 8.1 HCР-7710/17.12.2015; НСР-18287/28.03.2019 12.04.2019 02.05.2019 Неактивен 1971
Venlafaxine 20080091 ELIFY XR, Prolonged release capsule, hard, 75, mg, Pack: 30 Medochemie Ltd., Кипър Medochemie Ltd., Cyprus 6.45 1.29 7.74 7% 0.45 6.9 1.38 8.28 20% 1.29 8.19 1.64 9.83 HCР-7710/17.12.2015 02.01.2016 02.01.2016 Неактивен 1971
Venlafaxine 20080091 ELIFY XR, Prolonged release capsule, hard, 75, mg, Pack: 30 Medochemie Ltd., Кипър Medochemie Ltd., Cyprus 7.63 1.53 9.16 7% 0.53 8.16 1.63 9.79 20% 1.53 9.69 1.94 11.63 HCР-522/11.07.2013. 29.07.2013 29.07.2013 Неактивен 1971
Venlafaxine II-2247/ 11.06.2008 ELIFY XR, Prolonged release capsule, hard, 75, mg, Pack: 30 Medochemie Ltd., Кипър Medochemie Ltd, Cyprus 15.69 3.14 18.83 6% 0.94 16.63 3.33 19.96 18% 2.82 19.45 3.89 23.34 КЦРР-210/27.02.2012 20.03.2012 20.03.2012 Неактивен 1971
Venlafaxine II-2247/11.06.2008 ELIFY XR, Prolonged release capsule, hard, 75, mg, Pack: 30 Medochemie Ltd., Кипър Medochemie Ltd, Cyprus 21.32 4.26 25.58 8% 1.71 23.03 4.61 27.64 20% 4.26 27.29 5.46 32.75 КЦ-494/04.02.2009 24.02.2009 24.02.2009 Неактивен 1971
Leuprorelin 20070097 ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 Astellas Pharma d.o.o, Словения Astellas Pharma Europe B.V., The Netherlands 538.19 107.64 645.83 4% 10 548.19 109.64 657.83 16% 25 573.19 114.64 687.83 Корекционно решение НСР-16848/20.09.2018 НСР-6144/29.04.2015.; НСР-9624/23.06.2016г.; НСР-12144/27.03.2017 г.; НСР-14905/25.01.2018; НСР-17239/12.11.2018 предварително изпълнение; НСР-19369/26.07.2019 предварително изпълнение 26.07.2019 02.09.2019 Активен 3859
Leuprorelin 20070097 ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 Astellas Pharma d.o.o, Словения Astellas Pharma Europe B.V., The Netherlands 538.19 107.64 645.83 4% 10 548.19 109.64 657.83 16% 25 573.19 114.64 687.83 Корекционно решение НСР-16848/20.09.2018 НСР-6144/29.04.2015.; НСР-9624/23.06.2016г.; НСР-12144/27.03.2017 г.; НСР-14905/25.01.2018; НСР-17239/12.11.2018 предварително изпълнение; НСР-19369/26.07.2019 предварително изпълнение 26.07.2019 02.09.2019 Неактивен 3859
Leuprorelin 20070097 ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 Astellas Pharma d.o.o, Словения Astellas Pharma Europe B.V., The Netherlands 538.19 107.64 645.83 4% 10 548.19 109.64 657.83 16% 25 573.19 114.64 687.83 Корекционно решение НСР-16848/20.09.2018 НСР-6144/29.04.2015.; НСР-9624/23.06.2016г.; НСР-12144/27.03.2017 г.; НСР-14905/25.01.2018; НСР-17239/12.11.2018 предварително изпълнение; НСР-19369/26.07.2019 предварително изпълнение* 26.07.2019 02.08.2019 Неактивен 3859
Leuprorelin 20070097 ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 Astellas Pharma d.o.o, Словения Astellas Pharma Europe B.V., The Netherlands 553.79 110.76 664.55 4% 10 563.79 112.76 676.55 16% 25 588.79 117.76 706.55 Корекционно решение НСР-16848/20.09.2018 НСР-6144/29.04.2015.; НСР-9624/23.06.2016г.; НСР-12144/27.03.2017 г.; НСР-14905/25.01.2018; НСР-17239/12.11.2018 предварително изпълнение 12.11.2018 02.12.2018 Неактивен 3859
Leuprorelin 20070097 ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 Astellas Pharma d.o.o, Словения Astellas Pharma Europe B.V., The Netherlands 598.7 119.74 718.44 4% 10 608.7 121.74 730.44 16% 25 633.7 126.74 760.44 Корекционно решение НСР-16848/20.09.2018 НСР-6144/29.04.2015.; НСР-9624/23.06.2016г.; НСР-12144/27.03.2017 г.; НСР-14905/25.01.2018 09.02.2018 02.03.2018 Неактивен 3859
Leuprorelin 20070097 ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 Astellas Pharma d.o.o, Словения Astellas Pharma Europe B.V., The Netherlands 598.7 119.74 718.44 4% 10 608.7 121.74 730.44 16% 25 633.7 126.74 760.44 НСР-6144/29.04.2015.; НСР-9624/23.06.2016г.; НСР-12144/27.03.2017 г.; НСР-14905/25.01.2018 09.02.2018 02.03.2018 Неактивен 3859
Leuprorelin 20070097 ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 Astellas Pharma d.o.o, Словения Astellas Pharma Europe B.V., The Netherlands 611.55 122.31 733.86 4% 10 621.55 124.31 745.86 16% 25 646.55 129.31 775.86 НСР-6144/29.04.2015.; НСР-9624/23.06.2016г.; НСР-12144/27.03.2017 г. 11.04.2017 02.05.2017 Неактивен 3859
Leuprorelin 20070097 ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 Astellas Pharma d.o.o, Словения Astellas Pharma Europe B.V., The Netherlands 689.29 137.86 827.15 4% 10 699.29 139.86 839.15 16% 25 724.29 144.86 869.15 НСР-6144/29.04.2015.; НСР-9624/23.06.2016г. 02.08.2016 02.08.2016 Неактивен 3859
Leuprorelin 20070097 ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 Astellas Pharma d.o.o, Словения Astellas Pharma Europe B.V., The Netherlands 690.98 138.2 829.18 4% 10 700.98 140.2 841.18 16% 25 725.98 145.2 871.18 НСР-6144/29.04.2015. 14.05.2015 14.05.2015 Неактивен 3859
Leuprorelin 20060216 ELIGARD, Solution for injection, 7.5, mg, Pack: 1 Astellas Pharma d.o.o, Словения Astellas Pharma Europe B.V., The Netherlands 107.61 21.52 129.13 4% 4.3 111.91 22.38 134.29 16% 17.22 129.13 25.83 154.96 цената е заличена с решение НСР-6528/24.06.2015 (в сила от 16.07.2015 ) НСР-6226/21.05.2015 04.06.2015 04.06.2015 Заличен 3201
Leuprorelin 20070097 ELIGARD, Solution for injection, 22.5, mg, Pack: 1 Astellas Pharma d.o.o, Словения Astellas Pharma Europe B.V., The Netherlands 324.22 64.84 389.06 4% 10 334.22 66.84 401.06 16% 25 359.22 71.84 431.06 цената е заличена с решение НСР-6529/24.06.2015 (в сила от 16.07.2015 ) НСР-6227/21.05.2015 04.06.2015 04.06.2015 Заличен 3200
Leuprorelin 20060216 ELIGARD, Solution for injection, 7.5, mg, Pack: 1 Astellas Pharma d.o.o, Словения Astellas Pharma Europe B.V., The Netherlands 137.65 27.53 165.18 4% 5.51 143.16 28.63 171.79 16% 22.02 165.18 33.04 198.22 НСР-4652/25.09.2014 09.10.2014 09.10.2014 Неактивен 3201
Leuprorelin 20070097 ELIGARD, Solution for injection, 22.5, mg, Pack: 1 Astellas Pharma d.o.o, Словения Astellas Pharma Europe B.V., The Netherlands 354.46 70.89 425.35 4% 10 364.46 72.89 437.35 16% 25 389.46 77.89 467.35 НСР-4653/25.09.2014 09.10.2014 09.10.2014 Неактивен 3200
Leuprorelin 20070097 ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 Astellas Pharma d.o.o, Словения Astellas Pharma Europe B.V., The Netherlands 708.75 141.75 850.5 4% 10 718.75 143.75 862.5 16% 25 743.75 148.75 892.5 корекц решение НСР-3225/14.04.2014 НСР-2509/24.01.2014 21.03.2014 21.03.2014 Неактивен 3859
Leuprorelin 20070097 ELIGARD, Solution for injection, 22.5, mg, Pack: 1 Astellas Pharma d.o.o, Словения Astellas Pharma Europe B.V., The Netherlands 371.43 74.29 445.72 4% 10 381.43 76.29 457.72 16% 25 406.43 81.29 487.72 промяна на обстоятелства НСР-934/12.08.2013 НСР-447/09.07.2013 30.07.2013 30.07.2013 Неактивен 3200
Showing 4351 to 4376 of 16676 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте